Docstoc

resume

Document Sample
resume Powered By Docstoc
					                                                                            Updated 11/17/07



                                  WAREEF KABBANI, M.D.
                        University of Texas Southwestern Medical Center
                                     5323 Harry Hines Blvd.
                                     Dallas, TX 75390-9073
                                         (214) 590 1751
                         Email: wareef.kabbani@UTSouthwestern.edu


EDUCATION AND TRAINING

07/2001- 06/2002:        Fellow, Cytopathology.
                          University of Texas Southwestern Medical Center, Dallas Texas

07/2000- 06/2001:         Fellow, Surgical Pathology.
                          University Of Texas/ MD Anderson Cancer Center, Houston Texas

 07/1999-06/2000:        Chief Resident, Anatomic and Clinical Pathology.
                          Wayne State University

07/1996 – 06/2000:        Resident, Anatomic and Clinical Pathology.
                          Wayne State University

09/1995 -12/1995:         Resident, Anatomic Pathology.
                          Aleppo University

09/1988 - 11/1994:        Medical student.
                          Aleppo Medical School, Syria.


Board Certification:

       09/2001:        Diplomate, Anatomic and Clinical Pathology.
                       American Board of Pathology

       09/2003:        Diplomate, Cytopathology.
                       American Board of Pathology

Licenses:

       05/2001:        Indiana Medical License: 01054135A (Active)

       08/2002:        Texas Medical License: L4480 (Active)

Examinations:

       09/1995:        ECFMG Certification

       06/1995:        USMLE Step 1, Score: 94

       04/1995:        ECFMG English Examination

       08/1994:        USMLE Step 2, Score: 86

       05/1998:        USMLE Step 3, Score: 83

                                               1
                                                                                    Updated 11/17/07

     11/1994:         Doctor in Medicine (MD) Diploma


ACADEMIC APPOINTMENTS:

     April 2004- present:               Assistant professor, Department of Pathology, University of
                                        Texas Southwestern, Dallas, Texas

RESEARCH EXPERIENCE:

     Sep 1993- June 1994: Aleppo University Hospital.
     Epidemiological studies of the prevalence of Giardia infections in Aleppo.

     July 1997:                   Wayne State University.
     Kaposi’s Sarcoma, Molecular markers and morphologic studies
     104 cases of AIDS associated KS cases were studied including different morphologic features in
     systemic involvement of many organs. HHV virus was identified by electron microscopy. Cell cycle
     marker expression was investigated in relationship to tumor grade, developmental phase and host organ.

     Oct 1997-Nov 1997:                Wayne State University.
     Efficacy of Microscan fluorescence fast microbial identification and antibiotic sensitivity
     in urine cultures
     We have validated a novel fully automated technology for microorganisms identification and
     antibiotic sensitivity screening of urine cytology with an intended goal of saving technical
     time and improving sensitivity and specificity of this common microbiology test.

     Jul 2000- Jan 2001:                MD Anderson Cancer Center.
     The role of microsatellite instability and other molecular pathways in appendiceal
     carcinomas
     The frequency of microsatellite instability was not determined previously in appendiceal
     adenocarcinomas. Since many appendiceal tumors have mucinous differentiation a feature
     shared (at least focally) by many microsatellite instable colorectal adenocarcinomas, we
     hypothesized a similar pathway for primary appendiceal adenocarcinoma. Our data showed
     no microsatellite instability in all cases and rather other molecular pathways play some role
     in the carcinogenesis of these tumors. We have used p53 and K-ras to stratify appendiceal
     adenocarcinoma in to two groups that have two distinct biologic behavior and morphologic
     characteristics (mucinous and non-mucinous tumors).

     July 2001-June 2002: University of Texas Southwestern.
     Diagnostic applications of Cell cycle markers in patients with Pseudomyxoma Peritonei

     April 2004- Dec 2004: University of Texas Southwestern.
      Multtarget Fluorescent In-Situ Hybridization Urovysion probes validation for use as a
     clinical follow-up adjunct to Urine cytology for detecting urothelial carcinoma.




GRANTS:


                                                   2
                                                                             Updated 11/17/07
       March 2007: Sub-investigator. Multi-institutional NCI funded grant
       PI: Scott Lippman, M.D. (MD Anderson Cancer Center).
       Participating institutions: MD Anderson Cancer Center, Cleveland Clinic, University of
       Texas Southwestern, and University of Texas at San Antonio.
       A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride
       versus Placebo for Patients with Clinically Organ-Confined Prostate Cancer



       April 2006- present: Co-investigator. University of Texas Southwestern
       DoD grant. PI: Jer-Tsong Hsieh, PhD.
       Development of a Novel Strategy against the Advanced Prostate Cancer:
       Designing Peptides as Therapeutic Agents Based on the Aberrant
       Signaling.

       May 2006- present: Co-investigator.         University of Texas Southwestern
       NIH grant CA 113608
       PI: Jer-Tsong Hsieh, PhD.
       The role of DOC-2 and its application in prostate cancer


       September 2006-present
       DoD grant. PI: Jer-Tsong Hiseh
       Characterizing homeostatic control for prostate cell growth and differentiation (Sept.
       2006)


       November 1, 2004- present: Sub-investigator. University of Texas Southwestern
       CALGB 100017 study (NCI funded)
       PI: Laura Esserman, MD, MBA (University of California at San Francisco)
       Contrast-Enhanced Breast MRI and correlative science studies to characterize tumor
       response in patients undergoing neoadjuvant treatment for locally advanced breast
       cancer.

       June 2005- present: Sub-investigator. University of Texas Southwestern
       Protocol ML 18530 (ROCHE)
       Study Director: Carlos Moisa, MD, PI: Debu Tripathy, MD.
       An open label study of Capecetabine and Docetaxel as Neoadjuvant treatment for
       patients with recently diagnosed Her-2 Neu negative breast cancer plus Trastuzumab
       for Her-2 Neu positive cancer (Xena trial).




BIBLIOGRAPHY

Published Original Articles:
   1. Mnemonics and Schemes for Common Medical Entities, Kabbani W., Tarakji AR.,
      Aseel M., Aleppo University Publications, June: 6:1-34, 1994

                                                3
                                                                       Updated 11/17/07
2. Racial distribution of glands in the anterior compartment of the prostate gland. Tiguert
   R., Kabbani W, Gheiler E, Banerjee M., Sakr W., Pontes JE. Prostate. June 1; 39(4):
   310- 5. Presented in the USCAP meeting, 1999, San Francisco.
3. Genetic alterations in appendiceal adenocarcinomas: frequent k-ras mutations and lack
   of microsatellite instability. Kabbani W, Houlihan PS, Luthra R, Hamilton SR,
   Rashid A. Modern Pathology, June 1; 15(6): 599-605. Presented in the USCAP
   meeting, 2001, Atlanta.
4. Cell-block preparation in unsatisfactory cervicovaginal thin preps. Is it helpful?
   Kabbani W., Raisanen J., Ashfaq R. Accepted for the USCAP meeting, February
   2001, Chicago. Diagnostic Cytopathology, October 1; 27(4): 238-243.
5. Uterine Tumor Resembling Ovarian Sex-cord Tumor: Report of a Case Mimicking
   Cervical Adenocarcinoma. Wareef Kabbani, M.D.; Michael T. Deavers, M.D.; Anais
   Malpica, M.D.; Thomas W. Burke, M.D.; Jinsong Liu, M.D., Ph.D.; Nelson G.
   Ordoñez, M.D.; Anuja Jhingran, M.D.; Elvio G. Silva, M.D. International Journal of
   Gynecological Pathology. July 1; 22(3): 297-302
6. Application of novel hemostatic agent quikclot during laparoscopic partial
   nephrectomy. Vitaly Margulis, Edward D. Matsumoto, Robert Svatek, Wareef
   Kabbani, Jeffrey Cadeddu, and Yair Lotan. J Urol. 2005 Aug;174(2):761-4.

7. Effect of Radiofrequency Ablation on the urinary collecting system: Vitaly Margulis,
   Robert Svatek, Wareef Kabbani, and Jeffery Cadeddu. Urol. 2005 Jul;174(1):350-2.

8. Gastrointestinal Hemorrhage as First Manifestation of a Metastatic Testicular Tumor.
   Shahrokh F. Shariat, David Duchene, Zachary Mucher, Wareef Kabbani, Yair Lotan.
   Urology. 2005 Dec;66(6):1319

9. Histone Deacetylase Inhibitor (FK228) Enhances the Therapeutic Efficacy of
   Docetaxel in Androgen Independent Prostate cancer. Zhengwang Zhang, Jennifer
   Stanfield, Eugene Frenkel, Wareef Kabbani and Jer-Tsong Hsieh (in press).

10. ASC-H: Correlation with reflex HC2 HPV DNA Test and Biopsy Findings. Suad H.
   Taraif, Momin T. Siddiqui, Ann Marie West, Wareef Kabbani, William Griffith,
   Claudia Werner and Raheela Ashfaq. Cancer Cytopathology (manuscript in
   preparation).

11. The Role Of Combined Urine Cytology And Vysis Urovysion In Predicting Recurrent
    Urothelial Carcinoma.W Kabbani , S Traif , M Siddiqui , A Fulmer , D Wanzer , A
    Sagalowsky and R Ashfaq. Cancer Cytopathology (manuscript in preparation).

12. Efficacy Of Cyberknife® Stereotactic Radiosurgical Treatment For Localized Prostate
    Cancer: A Murine Model. Jennifer B. Sherwood, Jennifer Stanfield, Khaled F. Abdel-
    Aziz, Claus G. Roehrborn, Jt Hsieh, Karen Chang, Kenneth Forster, Wareef
    Kabbani, L. Chinsoo Cho, Hak Choy, And Yair Lotan. J Urol (May 2006, Ref# JU-
    05-1091R1)

13. Efficacy of High Dose per Fraction Radiation for Implanted Human Renal Cell
    Cancer in a Nude Mouse Model. L. Walsh, J. Stanfield, L. Chinsoo Cho, C. Chang, K.
    Forster, W. Kabbani, JT Hsieh, H. Choy, R. Timmerman and Y. Lotan. Eur Urol.
    2006 Mar 29

14. Nodular hidradenocarcinoma over the parotid gland: A pathologic presentation. Verret
    DJ, Kabbani W, Deffatta RJ. Head and neck, 13;29(2):193-197, November 2006.


                                           4
                                                                              Updated 11/17/07
   15. Rectal GIST Mimicking a Prostate Mass. Armin Ghobadi, Wareef Kabbani, Bradford
       Barker, and Jonathan Dowell. Accepted for publication in JCO.

   16. Zeltser IS, Gupta A, Park S, Dugi D, Kabbani W, Moonat S and Cadeddu JA: Does
      „FloSeal‟ topical hemostatic agent have an adverse effect on prostatic neurovascular
      bundle function? (Manuscript submitted to British Journal of Urology, BJU-2007-
      1247).


Published Abstracts and presentations:
   1. Correlative study of perineural invasion, neuro-endocrine differentiation and the stage and
       grade of clinically localized prostate cancer. Kabbani W, Sakr W, Grignon D, Wood D and
       Crissman J. Modern Pathology 11(1): 492A, 1998. Presented in the USCAP meeting, March
       1998, Boston, Nominated for Stowell- Orbison award competition.
   2. Herpes type viral particles in Kaposi sarcoma cells: An ultrastructural study. Adsay NV,
       Kabbani W., Ioachim H. Modern Pathology 11(1): 143A, 1998. Presented in the USCAP
       meeting, 1998, Boston.
   3. Zonal Anatomy of the prostate, a morphological study. Kabbani W., Butler C., Banerjee M.,
       Tiguert R., Edson JE., Sakr W. Crissman J.
   4. How much of a Sarcoma is Kaposi‟s sarcoma? Expression of cell cycle proteins and
       proliferation markers in KS. Kabbani W., Ioachim, Sarkar F., Adsay V, Crissman J. Modern
       Pathology 12(1): 816A, 1999. Presented in the USCAP meeting in March, 1999, San
       Fransisco.
   5. Morphologic patterns of Kaposi sarcoma (KS) and their diagnostic and biologic significance:
       A study of 103 cases. Cheng JD, Kabbani W., Adsay NV, Ioachim H., Lonardo F. Modern
       Pathology 13(1): 8A, 2000. Presented in the USCAP meeting, 2000, New Orleans.
   6. Infiltrating Lobular Type Carcinoma of the Pancreas: A morphologically distinctive variant
       of ductal adenocarcinoma of the pancreas mimicking lobular carcinoma of the breast. Adsay
       NV, Kabbani W. Sarkar F, Visscher D. Modern Pathology 12(1): 159A, 1999. Presented in
       the USCAP meeting, 1999, San Francisco.
   7. Chromophobic acinar cell change and atypical acinar micro-nodules in the pancreas: a study
       of two distinctive acinar cell derangements in the normal pancreas from pancreatectomy
       specimens. Kabbani W., Msallati Z, Adsay V. Modern Pathology 13(3): 1088A, 2000.
       Presented in the USCAP meeting, 2000, New Orleans. Nominated for Stowell Orbison award
       competition.
   8. Benign small ductular proliferations of the pancreas: mucinous adenosis (adenomatoid ductal
       hyperplasia), sclerosing adenosis (ductal hamartoma) and atrophic adenosis. Kabbani W.,
       Adsay VA. Modern Pathology 13(3): 1089A, 2000. Presented in the USCAP meeting, 2000,
       New Orleans.
   9. Tamoxifen suppresses histologic progression in Atypia and DCIS in MCFIOAT xenografts:
       A model of early breast cancer. Mills KM., Kabbani W., Visscher D., Nanjia-Makker P.,
       Heppner G., Shekhar PV. Modern Pathology 13(3): 142A, 2000. Presented in the USCAP
       meeting, 2000, New Orleans.
   10. Clinicopathologic analysis of „long-term‟ survivors of clinical pancreatic cancer. El-Dean
       Z.S, Pernick N., Kabbani W., Alrauskas P., Phillip P., Vaitkevicius V., Sheilds A., Tobi M.,
       Lucas C., Weaver D., Adsay V. Modern Pathology 14(1): 194A, 2001. Presented in the
       USCAP meeting, 2001, Atlanta.
   11. Pernick NL. Eldean ZS. Kabbani W., Phillip P, Shelids A, Adsay NV. Pancreatic ductal
       adenocarcinoma in young patients. Modern Pathology 14(1): 201A, 2001. Presented in the
       USCAP meeting, 2001, Atlanta.
   12. Genetic Alterations in Appendiceal Adenocarcinomas: Frequent K-Ras Mutations and Lack
       of Microsatellite Instability. Kabbani W., Houlihan PS., Luthra R., Hamilton SR., Rashid A.
       Modern Pathology 14(1): 500A, 2001. Presented as a poster nominated for the Stowell-
       Orbison award in the USCAP meeting, March 2001, Atlanta.



                                                 5
                                                                               Updated 11/17/07
   13. Her2Neu amplification detected by FISH in breast lobular lesions. Kabbani W., Ashfaq R.,
       Submitted for the USCAP meeting, February 2002, Chicago.
   14. Cell block preparation in unsatisfactory cervicovaginal Thin Prep smears. Is it helpful?
       Kabbani W., Raisanen J., Ashfaq R. Accepted for the USCAP meeting, February 2001,
       Chicago.
   15. Utilization of Fat Pad Fine Needle Aspiration for the Diagnosis of Systemic Amyloidosis.
       Balani J., Kabbani W., Ashfaq R. Submitted for presentation in the American Society of
       Cytopathology meeting, November2002, Salt Lake City.
   16. COX-2 and thymidylase synthase correlate with proliferative rates of mucinous tumors with
       diffuse peritoneal dissemination Brian W Loggie, Yun Wu, M. Hossein Saboorian, Wareef
       Kabbani, Jason Fleming, William H Frawley, Raheela Ashfaq, University of Texas
       Southwestern Medical Center, Dallas, TX. ASCO meeting, Year: 2002 Abstract No: 1798-4.
   17. SMAD-4 Alterations in Pancreatic Fine Needle Aspirations. Momin Siddiqui, Hossein
       Saboorian, Wareef Kabbani, and Raheela Ashfaq, University of Texas Southwestern,
       Dallas, TX. American Society of Cytopathology meeting, November2002, Salt Lake City,
       Platform presentation#9
   18. Efficacy of cyberknife® stereotactic radiosurgical treatment for localized prostate cancer: a
       murine model Jennifer B. Sherwood, Jennifer Stanfield, Khaled F. Abdel-Aziz, Claus G.
       Roehrborn, JT Hsieh, Karen Chang, Kenneth Forster, Wareef Kabbani, L. Chinsoo Cho,
       Hak Choy, and Yair Lotan. Submitted for AUA meeting in May 2005.
   19. ASC-H: Correlation with Reflex HC2 HPV DNA Test and Biopsy Findings.
       S Taraif, M T Siddiqui, A M West, W Griffith, W Kabbani, C Werner and R Ashfaq (in
       press). Accepted for Stowel Orbisson Award competition, USCAP meeting, San Antonio TX,
       Feb. 2005.
   20. The Role Of Combined Urine Cytology And Vysis Urovysion In Predicting Recurrent
       Urothelial Carcinoma.W Kabbani , S Traif , M Siddiqui , A Fulmer , D Wanzer , A
       Sagalowsky and R Ashfaq. Accepted for presentation in the USCAP meeting at San Antonio
       TX, Feb. 2005.
   21. Cytologic Diagnosis of Epithelioid Sarcoma: Utility of Immunohistochemistry to
       SMARCB1/INI1. J. Rasisanen, W. Kabbani. Submitted for the USCAP 2006 meeting,
       Atlanta GA.
   22. Mini-laparotomy retropubic radical Optical spectroscopy can differentiate Between benign
       and malignant tissue in Prostate specimens at surgery Altug tuncel, karim bensalah, ilia
       zeltser, jay raman, Disha peswani, wareef kabbani, hanli liu, jeffrey cadeddu. Journal of
       Endourology. 2007, 21(supplement 1): P8-P61. doi:10.1089/end.2007.WCE02
   23. Optical spectrophotometry can differentiate benign from malignant tumors at surgery: a
       pilot study. Karim bensalah, altug tuncel, ilia zeltser, jay raman, disha peswani, wareef
       kabbani, hanli liu, jeffrey cadededu. Journal of Endourology. 2007, 21(supplement 1): A1-
       A292. doi:10.1089/end.2007.WCE03.




Lectures, grand rounds, conferences and Attended Courses

Lectures:

   1. Sweat Gland Tumors simplified. Pathology grand rounds, MD Anderson Cancer Center,
      2001
   2. Unusual Tumors of the Female Genital System (1 and 2). Pathology grand rounds, MD
      Anderson Cancer Center, 2001
   3. Cytopathology for Pathology residents. Series of lectures presented to Pathology residents
      at University of Texas Southwestern, Dallas, 2001-2002
   4. FNA of the Thyroid Gland; what should the physician know? Didactic lecture presented
      at Bahrain Specialist Hospital, 2003


                                                 6
                                                                              Updated 11/17/07
   5. Genetic Testing for Malignancy; the Colorectal Model. Didactic Lecture presented in the
      CME program of Bahrain Specialist Hospital, 2003
   6. Evidence-Based Medicine; how much evidence makes evidence? A critical approach to
      the medical literature. Didactic lecture presented in the CME program of Bahrain Specialist
      Hospital, 2003
   7. Renal Tumors in Adults: Didactic lecture, AP lectures series for residents, University of
      Texas Southwestern, 2004.
   8. Primary Hepatic tumors: Didactic lecture, AP lecture series fro residents, University of
      Texas Southwestern, 2005.
   9. Soft Tissue Neoplasms: Didactic lecture, AP lecture series fro residents, University of Texas
      Southwestern, 2005.

Grand Rounds:
1. Spence Urologic Grand Rounds: University of Texas Southwestern, 2004- present.

Conferences

   1.   USCAP annual meetings 1998-2005
   2.   Detroit Pathology Society Monthly meetings, Detroit, MI, 1996-2000
   3.   Greater Houston Society of Clinical Pathologists meeting, Houston, TX, 2001
   4.   Texas Association of Pathologists, Fort Worth, TX, 2002, 2005
   5.   Breast Cancer; A multidisciplinary approach. Bahrain Association of Pathologists, Manama,
        Bahrain, 2003

Courses
   1. Long course in Hematopathology, USCAP meeting, Boston, March 1998
   2. Short course in the cytology of the breast, USCAP meeting, Boston, March, 1998
   3. Short course in the interpretation of frozen sections, USCAP meeting, Boston, March, 1998
   4. Long Course in Gynecologic Pathology, USCAP meeting, San Francisco, 1999
   5. Long course in Gastrointestinal Pathology, USCAP meeting, Chicago, 2002
   6. Short course in Molecular Pathology, USCAP meeting, Atlanta, 2001
   7. The 21st Annual Current Issues in Surgical Pathology, Dallas, TX. May 2002
   8. The 23 rd Annual Current Issues in Surgical Pathology, Dallas, TX. May 2004.
   9. Short course, “Problems in soft tissue tumors”, USCAP meeting, San Antonio 2005.
   10. Special course, “Introduction to molecular Pathology”, USCAP meeting, San Antonio, 2005.
   11. Short course, “Interactive cases in OBGYN Pathology”, USCAP meeting, Antlanta, 2006
   12. Short course, “ Sinonasal Pathology”, USCAP meeting, Atlanta, 2006
   13. Short course, “Cytology of Salivary glands”, USCAP meeting, Atlanta 2006
   14. Short course, “Uterine Pathlogy”, USCAP meeting, Atlanta 2006.




TEACHING EXPERIENCE

        07/2006- :             Lecturer, Lung and Head and Neck Pathology, Sophomore class, UT
                               Southwestern Medical Center, Dept of Pathology

        04/2004- :             Instructor, sophomore class, UT Southwestern Medical Center,
                               Department of Pathology

        07/2001- 06/2002:      Instructor, UT Southwestern Medical Center, Department of
                               Pathology



                                                7
                                                                              Updated 11/17/07
      07/2000- 06/2001:       Instructor, UT MD Anderson Cancer Center, Department of
                              Pathology

      07/1997-06/2000:        Instructor, Wayne State University of Medicine, Department of
                              Pathology

      09/1995- 12/1995:       Instructor, Aleppo University Medical School, Department of
                              Pathology


WORK EXPERIENCE

      04/2004-:               Pathologist, University of Texas Southwestern Medical center.
      09/2002- 03/2004:       Pathologist and Medical Director of Laboratory Services, Bahrain
                              Specialist Hospital, Manama, Bahrain.



INTERESTS AND SKILLS

  1. Non-Gynecological Cytopathology with emphasis on the technique and the art of
     interpretation including the use of adjunctive laboratory methods (Immunohistochemistry,
     flow cytometry, FISH, molecular pathology, etc.), in the diagnosis of tumors of unknown
     origin as well as the clinical implications of the biological markers.
  2. Gastrointestinal and Genitourinary tumor pathology with special interest in the
     pathogenesis and prognostic markers as well as investigating novel therapeutic targets for
     treatment of cancer.
  3. Laboratory administration in the Histology, Cytology and Microbiology


AWARDS AND HONORS

     Invited judge: Post-doc scientific abstract contest, University of Texas Southwestern,
      February 2005.
     Best doctor of the year: Bahrain Specialist Hospital, 2003
     Chief Resident: Wayne State University, Department of Pathology
     Rank of Excellence with Honor Graduation Degree: Aleppo University Medical School
      (4th Ranked Best Medical Student in 1994).
     Ranked 2nd in Aleppo, National Syrian Undergraduate School Exam
     Best student, Sophomore Year: Aleppo University Medical School

PROFESSIONAL ACTIVE MEMBERSHIPS

      1.   College of American Pathologists (1996- Present)
      2.   American Society of Clinical Pathology (2001- Present)
      3.   United States and Canadian Academy of Pathology (2001- Present)
      4.   Papanicolaou Society of Cytopathology, Member of the Scientific Committee (2002-
           2003).
      5.   American Society for Investigative Pathology (2001- Present)
      6.   American Medical Association (2002- Present)
      7.   Syrian Medical Association (1994- Present)
      8.   American Society of Cytopathology (2002- Present)
      9.   Texas Society of Cytopathology (2004- Present).


PROFESSIONAL COMMITTEES

                                               8
                                                                            Updated 11/17/07

     Cancer committee                                               St Paul University Hospital

                                                                    (2006- present)



     Genitourinary Tumor Repository Subcommittee:                   University of Texas
                                                                    Southwestern (2004- present).

     Ethics and Research committee:                                 Bahrain Specialist Hospital,
                                                                    (2003-2004).

     Scientific committee:                                          Papanicolaou Society of
                                                                    Cytopathology, 2002.



EXTRACURRICULAR ACTIVITIES

  1. Community Based camp, Rakka Hospitals, Rakka, Syria, 1993
  2. College of American Pathologists Inspection, VA medical Center, Detroit, 1997
  3. College of American Pathologists Inspection, Presbyterian Hospital of Plano, TX, 2002


PERSONAL

     Date of Birth: 6/1/1971
     Marital Status: Married
     Languages: Fluent in English and Arabic.
     Visa Status: H1b


REFERENCES

     KYLE MOLBERG, M.D., Professor and Director, Anatomic Pathology.
     University of Texas Southwestern
     5323 Harry Hines Blvd.
     Dallas, TX 75390-9073
     (214) 590 8676
     Kyle.Molberg@UTSouthwestern.edu

     RAHEELA ASHFAQ, M.D., Director of Cytopathology
     Department of Pathology
     UT Southwestern Medical Center
     5323 Harry Hines Blvd.
     Dallas, TX 75237
     (214) 590 8042
     Email: raheela.ashfaq@utsouthwestern.edu




                                                9
                                                            Updated 11/17/07

ALBERTO G. AYALA, M.D., Professor of Pathology
Department of Pathology
Methodist Hospital
Houston, TX 77030

JEFF MEDEIROS. M.D., Professor, Chief of Lymphoma Service
Department Of Pathology, Box 0085
UT MD Anderson Cancer Center
1515 Holcombe Ave.
Houston, TX 77030
(713) 794 5446
Email: jmedeiro@mdanderson.org

DAVID GRIGNON, M.D. Professor and Chairman of Pathology
Wayne State University
3990 John R., Detroit, MI 48201
(313) 745-8555
Email: dgrignon@med.wayne.edu




                                  10

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:126
posted:4/11/2010
language:English
pages:10